New report published by Global Info Research which offers insights on the global All Vaccine market.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body’s immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or “wild” pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
Click to view the full report TOC, figure and tables:
Global All Vaccine Market: Forecast by Type / Application / Region
The major players in China All Vaccine market include: CNBG, ChengDa Bio, Changsheng Life, Zhifei, SINOVAC BIOTECH, NuoCheng Bio, Hualan Bio, Kangtai, SANOFI PASTEUR S.A., Novartis and GSK.
On the basis of product, the All Vaccine market is primarily split into: Varicella, Influenza, Polio, Hepatitis A, Rabies, BCG, Hepatitis B, Pertussis, Diphtheria, tetanus, Pneumococcal and Other.
On the basis on the end users/applications covers:For Adult and For Child.
In the last several years, the market of China All Vaccine changed greatly, with an average growth rate of -6.47%. In 2016, revenue of China All Vaccine is nearly 2374.63 M USD; the actual sale is about 555.85 M Dose.
The average price of China All Vaccine is in the increasing trend, from 2.93 USD/Dose in 2012 to 4.27 USD/Dose in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of China All Vaccine includes Polio, Pertussis, Diphtheria, Tetanus, BCG, Rabies, Hepatitis B, Pneumococcal, Hepatitis A, Varicella, Influenza and others and the proportion of Pertussis, Diphtheria and Tetanus in 2016 is about 20.15%, and the proportion is in fluctuation trend from 2012 to 2016.
China All Vaccine is widely used by adults and children. The most proportion of China All Vaccine is children, and the sales market share in 2016 is 65.71%. The children proportion are decreasing.
Market competition is not intense. CNBG, ChengDa Bio, Changsheng Life, Zhifei, SINOVAC BIOTECH, NuoCheng Bio, Hualan Bio, Kangtai, SANOFI PASTEUR S.A., Novartis, GSK, etc. are the leaders of the industry in China, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Ask for Discount on Research Report and Request Sample Copy of Report@
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
United States All Vaccine Market 2018 Forecast to 2023
Europe All Vaccine Market 2018 Forecast to 2023
North America All Vaccine Market 2018 Forecast to 2023
Asia-Pacific All Vaccine Market 2018 Forecast to 2023
China All Vaccine Market 2018 Forecast to 2023
EMEA All Vaccine Market 2018 Forecast to 2023
Global All Vaccine Market 2018 Forecast to 2023
Contact US :
Sales Director (Global Info Research)
Tel: +86-15521064060 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong